Immunosuppressant (Whole Blood) Control, Level 1 250-1, Immunosuppressant (Whole Bloos) Control, Level 2, 250-2, Immun\S

FDA 510(k) K980331 · More Diagnostics

Substantially Equivalent

510(k) numberK980331

Submission

Device name
Immunosuppressant (Whole Blood) Control, Level 1 250-1, Immunosuppressant (Whole Bloos) Control, Level 2, 250-2, Immun\S
Applicant
More Diagnostics
Los Osos, CA, US
Received
January 28, 1998
Decision date
March 16, 1998
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) statement available from FDA

Official FDA 510(k) record

Device classification

Product code
DIF – Drug Mixture Control Materials
Device class
Class I (low risk)
Regulation
21 CFR 862.3280
Specialty
Clinical Toxicology

Other 510(k)s with product code DIF

510(k)DeviceApplicantDecision
K153474Detectabuse Liquid Control Urine, Detectabuse Stat-Skreen Liquid Control Urine…DIF · Traditional Biochemical Diagnostics, Inc.02/23/2016SE
K132688Salivabuse Liquid Oral Fluid Control, Salivabuse Liquid Oral Fluid Control, Au/NzDIF · Traditional Biochemical Diagnostics, Inc.12/16/2013SE
K132174Multichem WBTDIF · Abbreviated Techno-Path Manufacturing , Ltd.09/20/2013SE
K121122Detectabuse Liquid Control, Detectabuse Stat-Skreen Liquid ControlDIF · Traditional Biochemical Diagnostic, Inc.07/03/2012SE
K121143Liquichek Whole Blood Immunosuppressant Control Tilevel (1,2 and 3)DIF · Traditional Bio-Rad Laboratories05/18/2012SE
K120504Liquichek Urine Toxicology Control, S10 & S10 Minipak, Liquichek Urine Toxicology…DIF · Traditional Bio-Rad Laboratories, Inc.03/27/2012SE
K103656Thermo Scientific Mas R Doa TotalDIF · Traditional Microgenics Corporation03/24/2011SE
K093577Liquichek Opiate ControlDIF · Traditional Bio-Rad Laboratories03/12/2010SE
K080085Mas Tox ControlDIF · Traditional Thermo Fisher Scientific04/30/2008SE
K080183Control Set Dat I, Contrl Set Dat II, Control Set Dat III, Control Set Amphetamine 1000…DIF · Abbreviated Roche Diagnostics Corp.03/25/2008SE

More from Roche Diagnostics Corp.

510(k)DeviceDecision
K072257Mycophenolic Acid Control, Level 1, 2, 3, 4, 4-LEVELLAS · Traditional 01/30/2008SE
K050125Rap/Tac/Csa Control - Level 1,2,3,4JJY · Traditional 03/18/2005SE
K982845Cardiac Markers Control (Single Use)-Levels, 1,2,3, Models Number 175-1, 175-2, 175-3JJT · Traditional 08/21/1998SE
K972976Cardiac Markers Control - Level 1, Level 2, Level 3, Tri-LevelJJT · Traditional 08/29/1997SE
K970778Lead Control (Whole Blood) Levels 1,2,3,4JJX · Traditional 04/17/1997SE
K946193Fibrinogen Control (Human) Level 1, 2, 3GIL · Traditional 08/24/1995SE
K943571Multi-Level Control for Fibrin Degradation ProductsDAP · Traditional 06/15/1995SE
K944999Serum Bilirubin Control- Level 1, 2 and 3JJX · Traditional 06/06/1995SE
K941876Whole Blood Volatiles Control, Levels 1 and 2JJY · Traditional 07/28/1994SE
K941698Serum Volatiles Control - Levels 1 and 2JJY · Traditional 07/28/1994SE

Questions and answers

When was Immunosuppressant (Whole Blood) Control, Level 1 250-1, Immunosuppressant (Whole Bloos) Control, Level 2, 250-2, Immun\S cleared by the FDA?

Immunosuppressant (Whole Blood) Control, Level 1 250-1, Immunosuppressant (Whole Bloos) Control, Level 2, 250-2, Immun\S (K980331) received a 510(k) decision of Substantially Equivalent on March 16, 1998, 47 days after the submission was received.

What is the product code of K980331?

The FDA product code is DIF – Drug Mixture Control Materials, a Class I (low risk) device regulated under 21 CFR 862.3280.